Fujifilm Diosynth Biotechnologies, United Kingdom, is responsible for microbial production process development, scale up, validation and GMP production for the PRS-080 molecule.

FUJIFILM Diosynth Biotechnologies is an industry leading Biologics Contract Manufacturing Organisation with locations in Billingham, United Kingdom and Research Triangle Park, North Carolina, USA. Fujifilm Diosynth Biotechnologies has extensive experience in the development and manufacturing of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules expressed in a wide array of microbial, mammalian, and insect systems.

The company offers a comprehensive list of services from cell line development including its proprietary pAVEway™ system to process development, analytical development, clinical and commercial manufacturing. Both sites are FDA-approved for the production of commercial products.

For more information, please contact: Bridget Hall
Communications Manager
Fujifilm Diosynth Biotechnologies
Telephone: +44 (0)1642 367320
E-mail: bridget.hall "at" fujifilmdb.com
www.fujifilmdiosynth.com